FDA-approved
Digestive & weight
Ga-68 dotatate
Evidence
FDA approved
Class
Radiolabeled somatostatin analog (imaging)
KEY TAKEAWAY
Gallium Ga 68 dotatate is a somatostatin-receptor-binding peptide attached to a radioactive gallium atom. It is sold as Netspot. The FDA approved Ga-68 dotatate (Netspot) in 2016 as an imaging agent for neuroendocrine tumors that carry somatostatin receptors.
Written by the Veylo editorial team · Updated
November 2026
What it is
Radiolabeled somatostatin analog (imaging)
Approved for
PET imaging of neuroendocrine tumors
Key fact
The FDA approved Ga-68 dotatate (Netspot) in 2016 as an imaging agent for neuroendocrine tumors that carry somatostatin receptors.
Route
Single intravenous injection before a PET scan
Evidence strength
FDA approved
Gallium Ga 68 dotatate is a somatostatin-receptor-binding peptide attached to a radioactive gallium atom. It is sold as Netspot.
The peptide binds somatostatin receptors, which are abundant on neuroendocrine tumors, and the radioactive tag lets a PET scan show where those tumors are.
The FDA approved Ga-68 dotatate (Netspot) in 2016 as an imaging agent for neuroendocrine tumors that carry somatostatin receptors.
PET imaging of neuroendocrine tumors.
As a diagnostic it involves a small dose of radiation. Side effects are uncommon and mild.
U.S. FDA prescribing information for Ga-68 dotatate. DailyMed, National Library of Medicine.
Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.